MV Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.27M | Buy |
2,472
+4
| +0.2% | +$4.05K | 0.22% | 74 |
|
|
2025
Q4 | $2.65M | Buy |
2,468
+10
| +0.4% | +$9.56K | 0.25% | 72 |
|
|
2025
Q3 | $1.88M | Hold |
2,458
| – | – | 0.18% | 81 |
|
|
2025
Q2 | $1.92M | Sell |
2,458
-8
| -0.3% | -$6.22K | 0.2% | 79 |
|
|
2025
Q1 | $2.04M | Buy |
2,466
+177
| +8% | +$147K | 0.22% | 78 |
|
|
2024
Q4 | $1.77M | Sell |
2,289
-6
| -0.3% | -$4.97K | 0.19% | 81 |
|
|
2024
Q3 | $2.03M | Buy |
2,295
+12
| +0.5% | +$10.8K | 0.22% | 79 |
|
|
2024
Q2 | $2.07M | Buy |
2,283
+19
| +0.8% | +$15.2K | 0.23% | 71 |
|
|
2024
Q1 | $1.76M | Buy |
2,264
+4
| +0.2% | +$2.85K | 0.2% | 79 |
|
|
2023
Q4 | $1.32M | Buy |
2,260
+11
| +0.5% | +$6.42K | 0.17% | 74 |
|
|
2023
Q3 | $1.21M | Buy |
2,249
+25
| +1% | +$12.9K | 0.16% | 80 |
|
|
2023
Q2 | $1.04M | Buy |
2,224
+43
| +2% | +$18K | 0.14% | 79 |
|
|
2023
Q1 | $749K | Buy |
2,181
+24
| +1% | +$8.09K | 0.11% | 88 |
|
|
2022
Q4 | $789K | Buy |
2,157
+12
| +0.6% | +$4.25K | 0.12% | 81 |
|
|
2022
Q3 | $694K | Buy |
2,145
+966
| +82% | +$306K | 0.12% | 85 |
|
|
2022
Q2 | $382K | Buy |
1,179
+13
| +1% | +$3.9K | 0.07% | 104 |
|
|
2022
Q1 | $334K | Buy |
1,166
+40
| +4% | +$10.3K | 0.05% | 115 |
|
|
2021
Q4 | $311K | Buy |
1,126
+17
| +2% | +$4.31K | 0.05% | 117 |
|
|
2021
Q3 | $256K | Buy |
1,109
+81
| +8% | +$20K | 0.04% | 115 |
|
|
2021
Q2 | $236K | Buy |
1,028
+105
| +11% | +$21.1K | 0.04% | 118 |
|
|
2021
Q1 | $172K | Buy |
923
+18
| +2% | +$3.52K | 0.03% | 121 |
|
|
2020
Q4 | $153K | Hold |
905
| – | – | 0.03% | 114 |
|
|
2020
Q3 | $134K | Buy |
905
+542
| +149% | +$83.9K | 0.03% | 109 |
|
|
2020
Q2 | $60K | Hold |
363
| – | – | 0.01% | 147 |
|
|
2020
Q1 | $50K | Buy |
363
+58
| +19% | +$7.97K | 0.01% | 149 |
|
|
2019
Q4 | $40K | Buy |
305
+62
| +26% | +$7.19K | 0.01% | 171 |
|
|
2019
Q3 | $27K | Buy |
243
+52
| +27% | +$5.79K | 0.01% | 189 |
|
|
2019
Q2 | $21K | Buy |
191
+4
| +2% | +$471 | ﹤0.01% | 197 |
|
|
2019
Q1 | $24K | Hold |
187
| – | – | 0.01% | 185 |
|
|
2018
Q4 | $22K | Hold |
187
| – | – | 0.01% | 190 |
|
|
2018
Q3 | $20K | Hold |
187
| – | – | 0.01% | 202 |
|
|
2018
Q2 | $16K | Hold |
187
| – | – | ﹤0.01% | 215 |
|
|
2018
Q1 | $14K | Hold |
187
| – | – | ﹤0.01% | 220 |
|
|
2017
Q4 | $16K | Hold |
187
| – | – | ﹤0.01% | 218 |
|
|
2017
Q3 | $16K | Hold |
187
| – | – | ﹤0.01% | 217 |
|
|
2017
Q2 | $15K | Hold |
187
| – | – | ﹤0.01% | 220 |
|
|
2017
Q1 | $16K | Hold |
187
| – | – | 0.01% | 213 |
|
|
2016
Q4 | $14K | Buy |
+187
| New | +$13.9K | 0.01% | 207 |
|
|
2015
Q2 | – | Sell |
-41
| Closed | -$3K | – | 435 |
|
|
2015
Q1 | $3K | Sell |
41
-66
| -62% | -$4.7K | ﹤0.01% | 369 |
|
|
2014
Q4 | $7K | Buy |
+107
| New | +$7.22K | ﹤0.01% | 327 |
|
Other funds holding LLY
VCM
VPM
MV Capital Management's LLY Position: Q1 2026 in Review
MV Capital Management increased its Eli Lilly (LLY) stake by 0.16% in Q1 2026, buying an estimated $4.05K and bringing the position to 2,472 shares worth $2.27M. The position accounts for 0.22% of the portfolio, ranked #74.
MV Capital Management first reported a position in LLY in Q4 2014 and has held it in 40 quarters since. The position peaked at $2.65M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- MV Capital Management held 2,472 shares of Eli Lilly worth $2.27M as of Q1 2026.
- MV Capital Management bought 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
- Eli Lilly made up 0.22% of MV Capital Management's portfolio in Q1 2026, its #74 holding.
- MV Capital Management first reported a position in Eli Lilly in Q4 2014 and has held it in 40 quarters since.
- MV Capital Management's Eli Lilly position peaked at $2.65M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on MV Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.